A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia - Related Studies

A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia

This study has been completed.

Study NCT00002067. Last updated on October 1, 2007. Information provided by Bristol-Myers Squibb

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Anorexia
		Cachexia
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Infection

3	More general conditions related to this trial
		Body Weight
		Body Weight Changes
		Emaciation
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Signs and Symptoms
		Signs and Symptoms, Digestive
		Slow Virus Diseases
		Virus Diseases
		Weight Loss

4	Interventions listed in this trial
		Megestrol acetate

5	Additional drug interventions recognized in this trial
		Megestrol

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Appetite Stimulants
		Central Nervous System Agents
		Central Nervous System Stimulants
		Contraceptive Agents
		Contraceptive Agents, Female
		Contraceptives, Oral
		Contraceptives, Oral, Synthetic
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Bristol-Myers Squibb